| Ansøgningsnr. og dato | 16151719.8 (espacenet) (Federated) (European Patent Register), 20110929 | | Patent/reg.nr. og dato | DK/EP 3040333, 20180912 | | Tilgængelighedsdato | 20160706 | | Prioritetsnr. og dato | US 388721 P, 20101001, US 201161494915 P, 20110609 | | EP publ. nr. og dato |
EP 3040333 20160706 | | Løbedag | | | Ansøger/indehaver | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Ansøgers ref. nr. | V1811-053-DK | | Opfinder | CALIENNI, John Vincent, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
DE LA CRUZ, Marilyn, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
GONG, Baoqing, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
KARPINSKI, Piotr H., Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
LIU, Hui, 2 Blue Ridge Avenue
Green Brook, New Jersey 08812, US,
WAYKOLE, Liladhar Murlidhar, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
FLUBACHER, DIETMAR, Novartis Pharma AG
CH-4002 Basel, CH,
MICHEL, Pascal, Novartis Pharma AG
CH-4002 Basel, CH,
MOSE, Rasmus, Novartis Pharma AG
CH-4002 Basel, CH,
TESTA, Maria Caterina, Novartis Pharma AG
CH-4002 Basel, CH,
KAPA, Prasad Koteswara, Novartis Pharmaceuticals Corporation One Health
Plaza
East Hanover, New Jersey 07936, US | | Fuldmægtig | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/535 (2006.01) , A61P 35/00 (2006.01) , C07D 401/04 (2006.01) | | Titel/benævnelse | KRYSTALLINSKE FORMER AF 5-(2,6-DI-4-MORPHOLINYL-4-PYRIDMIDINYL)-4-TRIFLUORMETHYLPYRIDIN-2-AMIN, EN PIK3-HÆMMER | | Internationalt ansøgningsnr. | | | Internationalt publ. nr. | | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
